SCOTT GRAUPNER, D.O.
Hematology & Oncology Physician · WEST COLUMBIA, SC
Individual Active NPI 1821438714
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,150 | 243,082 | $14,547,613 | $5,201,257 | $4,150,583 |
| 2023 | 1,054 | 236,974 | $13,710,930 | $4,591,103 | $3,657,786 |
| 2022 | 1,064 | 203,871 | $10,803,590 | $3,669,461 | $2,926,940 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 39,750 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 25,200 | $55 | $44 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 14,628 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 14,120 | $31 | $25 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 12,300 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 11,440 | $2 | $1 |
| J1453 | Injection, fosaprepitant, 1 mg | 11,100 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,570 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 10,320 | $25 | $20 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,380 | $45 | $35 |
| J9267 | Injection, paclitaxel, 1 mg | 5,445 | $0 | $0 |
| J9022 | Injection, atezolizumab, 10 mg | 2,880 | $84 | $67 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 83035 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in South Carolina
- NPI 1699207886
- NPI 1841223047
- NPI 1952509671
- NPI 1164509873
- NPI 1700021847
- NPI 1801123864
- NPI 1932706264
- NPI 1548293749
See all Hematology & Oncology Physician providers in South Carolina →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.